{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:33:18Z","timestamp":1790803998756,"version":"4.1.0"},"reference-count":11,"publisher":"Termedia Sp. z.o.o.","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Reumatologia"],"published-print":{"date-parts":[[2019,2,28]]},"abstract":"<jats:p>Lyme disease is a multisystem tick-borne transmissive disease with heterogeneous manifestations, frequently making the diagnosis difficult in clinical practice. Herein, we report a case of a 43-year-old female patient who presented with generalized lymphadenopathy requiring a further diagnostic evaluation towards lymphoma. The patient also had clinical signs of Sj\u00f6gren\u2019s syndrome. Lymph node excision with subsequent histological and immunohistochemical studies were performed. While light microscopy findings were suspicious for lymphoma, immunohistochemistry results were consistent with cortical and paracortical lymph node hyperplasia with no evidence of lymphoproliferative disorder. Further laboratory testing confirmed the presence of Lyme borreliosis. Effectiveness of the administered antibiotic therapy confirmed Borrelia burgdorferi infection. Interrelationships between Sj\u00f6gren\u2019s syndrome, lymphadenopathy and Lyme disease are discussed.<\/jats:p>","DOI":"10.5114\/reum.2019.83242","type":"journal-article","created":{"date-parts":[[2019,3,11]],"date-time":"2019-03-11T08:04:46Z","timestamp":1552291486000},"page":"59-62","source":"Crossref","is-referenced-by-count":12,"title":["Sj\u00f6gren\u2019s syndrome and lymphadenopathy unraveling the diagnosis of Lyme disease"],"prefix":"10.5114","volume":"57","author":[{"given":"Svitlana","family":"Smiyan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Galaychuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Zhulkevych","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volodymyr","family":"Nykolyuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Komorovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofiya","family":"Gusak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Bilozetsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3061","published-online":{"date-parts":[[2019,2,28]]},"reference":[{"key":"ref-775707","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.advms.2015.10.007","article-title":"Lyme disease in Poland \u2013 a serious problem?","volume":"61","author":"Czupryna P","year":"2016","unstructured":"Czupryna P, Moniuszko-Malinowska A, Pancewicz S, et al. (2016). Lyme disease in Poland \u2013 a serious problem? Adv Med Sci. 61: 96-100.","journal-title":"Adv Med Sci"},{"key":"ref-775708","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3844\/ajidsp.2018.1.44","article-title":"Chronic Lyme disease: a working case definition","volume":"14","author":"Stricker RB","year":"2018","unstructured":"Stricker RB, Fesler MC. (2018). Chronic Lyme disease: a working case definition Am J Inf Dis. 14: 1-44.","journal-title":"Am J Inf Dis"},{"key":"ref-775709","first-page":"473","article-title":"Lyme disease: a unique human model for an infectious etiology of rheumatic disease","volume":"57","author":"Malawista SE","year":"1984","unstructured":"Malawista SE, Steere AC, Hardin JA. (1984). Lyme disease: a unique human model for an infectious etiology of rheumatic disease Yale J Biol Med. 57: 473-477.","journal-title":"Yale J Biol Med"},{"key":"ref-775710","first-page":"40","article-title":"Modern aspects of etiology, pathogenesis, clinical course and treatment of Lyme arthritis (review, own observations)","volume":"72","author":"Smiyan SI","year":"2018","unstructured":"Smiyan SI, Shkilna MI, Regalyuk VV, et al. (2018). Modern aspects of etiology, pathogenesis, clinical course and treatment of Lyme arthritis (review, own observations) Ukr J Rheumatol. 72: 40-45.","journal-title":"Ukr J Rheumatol"},{"key":"ref-775711","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/cid\/ciu397","article-title":"Lyme disease testing by large commercial laboratories in the United States","volume":"59","author":"Hinckley AF","year":"2014","unstructured":"Hinckley AF, Connally NP, Meek JI, et al. (2014). Lyme disease testing by large commercial laboratories in the United States Clin Infect Dis. 59: 676-681.","journal-title":"Clin Infect Dis"},{"key":"ref-775712","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/annrheumdis-2016-210571","article-title":"2016 American College of Rheumatology\/European League Against Rheumatism classification criteria for primary Sj\u00f6gren\u2019s syndrome: a consensus and data-driven methodology involving three international patient cohorts","volume":"76","author":"Shiboski CH","year":"2017","unstructured":"Shiboski CH, Shiboski SC, Seror R, et al, International Sj\u00f6gren\u2019s Syndrome Criteria Working Group. (2017). 2016 American College of Rheumatology\/European League Against Rheumatism classification criteria for primary Sj\u00f6gren\u2019s syndrome: a consensus and data-driven methodology involving three international patient cohorts Ann Rheum Dis. 76: 9-16.","journal-title":"Ann Rheum Dis"},{"key":"ref-775713","doi-asserted-by":"crossref","first-page":"e1002066","DOI":"10.1371\/journal.ppat.1002066","article-title":"Lymphoadenopathy during Lyme borreliosis is caused by spirochete migration-induced specific B-cell activation","volume":"7","author":"Tunev SS","year":"2011","unstructured":"Tunev SS, Hastey CJ, Hodzic E, et al. (2011). Lymphoadenopathy during Lyme borreliosis is caused by spirochete migration-induced specific B-cell activation PLoS Pathog. 7: e1002066.","journal-title":"PLoS Pathog"},{"key":"ref-775714","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/art.39866","article-title":"Autoimmune arthritides, rheumatoid arthritis, psoriatic arthritis, or peripheral spondyloarthropathy, following Lyme disease","volume":"69","author":"Arvikar SL","year":"2017","unstructured":"Arvikar SL, Crowley JT, Sulka KB, Steere AC. (2017). Autoimmune arthritides, rheumatoid arthritis, psoriatic arthritis, or peripheral spondyloarthropathy, following Lyme disease Arthritis Rheum. 69: 194-202.","journal-title":"Arthritis Rheum"},{"key":"ref-775715","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3389\/fmed.2018.00102","article-title":"Lymphoma and lymphomagenesis in primary Sj\u00f6gren\u2019s syndrome","volume":"5","author":"Alunno A","year":"2018","unstructured":"Alunno A, Leone MC, Giacomelli R, et al. (2018). Lymphoma and lymphomagenesis in primary Sj\u00f6gren\u2019s syndrome Front Med (Lausanne). 5: 102.","journal-title":"Front Med (Lausanne)"},{"key":"ref-775716","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3816\/CLM.2006.n.003","article-title":"Infectious agents in mucosa-associated lymphoid tissue-type lymphomas: pathogenic role and therapeutic perspectives","volume":"6","author":"Guidoboni M","year":"2006","unstructured":"Guidoboni M, Ferreri AJ, Ponzoni M, et al. (2006). Infectious agents in mucosa-associated lymphoid tissue-type lymphomas: pathogenic role and therapeutic perspectives Clin Lymphoma Myeloma. 6: 289-300.","journal-title":"Clin Lymphoma Myeloma"},{"key":"ref-775717","doi-asserted-by":"crossref","first-page":"4681","DOI":"10.1128\/IAI.05242-11","article-title":"Role of interleukin-23 (IL-23) receptor signaling for IL-17 responses in human Lyme disease","volume":"79","author":"Oosting M","year":"2011","unstructured":"Oosting M, ter Hofstede H, van de Veerdonk FL, et al. (2011). Role of interleukin-23 (IL-23) receptor signaling for IL-17 responses in human Lyme disease Infect Immun. 79: 4681-4687.","journal-title":"Infect Immun"}],"container-title":["Rheumatology"],"original-title":[],"link":[{"URL":"https:\/\/reu.termedia.pl\/pdf-102836-85790","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/reu.termedia.pl\/pdf-102836-85790","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T08:09:35Z","timestamp":1674806975000},"score":1,"resource":{"primary":{"URL":"https:\/\/reu.termedia.pl\/Sjogren-s-syndrome-and-lymphadenopathy-unraveling-the-diagnosis-of-Lyme-disease,102836,0,2.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,28]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019]]}},"alternative-id":["102836"],"URL":"https:\/\/doi.org\/10.5114\/reum.2019.83242","relation":{},"ISSN":["0034-6233","2084-9834"],"issn-type":[{"value":"0034-6233","type":"print"},{"value":"2084-9834","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,28]]}}}